No big deal, right? After all, most medical-marijuana patients partake solely for the medicinal benefits, right? Surely they don't care about getting high?
(We'll pause here as screams of panic ring out from from the fertile hills of Humboldt County, Calif. to the dispensaries of Boulder, Colo. and on over to the coffee shops of Amsterdam.)
"Sometimes the high is not always what they need. Sometimes it is an unwanted side effect. For some of the people it's not even pleasant," Zack Klein, head of development at Tikun Olam, told Reuters.
After researching CBD-enriched cannabis since 2009, Tikun Olam came up with Avidekel six months ago.
Raphael Mechoulam, a professor of medicinal chemistry at the Hebrew University in Jerusalem, told Reuters he thought Avidekel is one of a kind.
"It is possible that" Avidekel's "CBD to THC ratio is the highest among medical marijuana companies in the world, but the industry is not very organised, so one cannot keep exact track of what each company is doing," he explained.